Literature DB >> 18387266

New hope for an oral cancer solution: together we can make a difference.

Miriam P Rosin1, Catherine F Poh, J Mark Elwood, P Michele Williams, Richard Gallagher, Calum MacAulay, Wan W Lam, Ajit Auluck, Lewei Zhang, T Gregory Hislop.   

Abstract

Oral cancer is associated with high mortality and morbidity rates, largely as a result of late diagnosis. Although dental practitioners are trained to identify premalignant and malignant lesions, an organized system is needed to offer guidance and to improve access to experts in diagnosis and management of these lesions. In this article, we describe the many ways in which the British Columbia Oral Cancer Prevention Program (BC OCPP) is addressing this challenge: by linking community dental practices and referral centres, by creating partnerships between scientists and clinicians that already have resulted in new technologies to enhance early diagnosis, by involving a broad range of stakeholders to ensure population-based screening and by engaging in provincial, national and international outreach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387266      PMCID: PMC2387224     

Source DB:  PubMed          Journal:  J Can Dent Assoc        ISSN: 0709-8936            Impact factor:   1.316


  18 in total

1.  Mouth cancer in India: a new epidemic?

Authors:  P C Gupta
Journal:  J Indian Med Assoc       Date:  1999-09

2.  High frequency of allelic loss in dysplastic lichenoid lesions.

Authors:  L Zhang; X Cheng; Y Li; C Poh; T Zeng; R Priddy; J Lovas; P Freedman; T Daley; M P Rosin
Journal:  Lab Invest       Date:  2000-02       Impact factor: 5.662

3.  Guideline for the early detection of oral cancer in British Columbia 2008.

Authors: 
Journal:  J Can Dent Assoc       Date:  2008-04       Impact factor: 1.316

4.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment.

Authors:  L Mao; J S Lee; Y H Fan; J Y Ro; J G Batsakis; S Lippman; W Hittelman; W K Hong
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

5.  Genetic progression model for head and neck cancer: implications for field cancerization.

Authors:  J Califano; P van der Riet; W Westra; H Nawroz; G Clayman; S Piantadosi; R Corio; D Lee; B Greenberg; W Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

6.  Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.

Authors:  Lewei Zhang; Michele Williams; Catherine F Poh; Denise Laronde; Joel B Epstein; Scott Durham; Hisae Nakamura; Ken Berean; Alan Hovan; Nhu D Le; Greg Hislop; Robert Priddy; John Hay; Wan L Lam; Miriam P Rosin
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

7.  3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.

Authors:  Miriam P Rosin; Wan L Lam; Catherine Poh; Nhu D Le; Robert Jinze Li; Tao Zeng; Robert Priddy; Lewei Zhang
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

8.  Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.

Authors:  Martial Guillaud; Lewei Zhang; Catherine Poh; Miriam P Rosin; Calum MacAulay
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer.

Authors:  M Partridge; G Emilion; S Pateromichelakis; R A'Hern; E Phillips; J Langdon
Journal:  Oral Oncol       Date:  1998-03       Impact factor: 5.337

Review 10.  Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms.

Authors:  Urmila Nair; Helmut Bartsch; Jagadeesan Nair
Journal:  Mutagenesis       Date:  2004-07       Impact factor: 3.000

View more
  5 in total

Review 1.  Advances in fluorescence imaging techniques to detect oral cancer and its precursors.

Authors:  Dongsuk Shin; Nadarajah Vigneswaran; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Future Oncol       Date:  2010-07       Impact factor: 3.404

2.  Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.

Authors:  Ian Cromwell; Dean A Regier; Stuart J Peacock; Catherine F Poh
Journal:  Oncologist       Date:  2016-07-11

Review 3.  Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct.

Authors:  Naveen Chhabra; Shruti Chhabra; Nitin Sapra
Journal:  J Maxillofac Oral Surg       Date:  2014-07-29

4.  Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities.

Authors:  Victor D Martinez; Calum E MacAulay; Martial Guillaud; Wan L Lam; Lewei Zhang; Kitty K Corbett; Miriam P Rosin
Journal:  Oral Oncol       Date:  2014-09-16       Impact factor: 5.337

5.  Low cost technology for screening early cancerous lesions of oral cavity in rural settings.

Authors:  A Parashari; V Singh; T Mittal; S Ahmed; H Grewal; S Gupta; A Sehgal
Journal:  Ann Med Health Sci Res       Date:  2014-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.